Skip to main content

NCI Renews 'Comprehensive' Status for UCSD's Moores Center, Grants $21M

NEW YORK (GenomeWeb News) — The National Cancer Institute has renewed the Moores Cancer Center’s status as a Comprehensive Cancer Center and has funded it with $21 million over five years, the University of California at San Diego said this week.
 
UCSD said it will use the grant to fund research costs and operational expenses for its 10 core facilities, which include labs and hardware for DNA sequencing, microarraying, bioinformatics, clinical trials, and other genomics, imaging, and cancer-related development endeavors.
 
The center, one of 40 nationwide designated a Comprehensive Cancer Center, has a staff of 330 researchers and clinicians. It moved into a 270,000-square-foot building in 2005.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.